HomeCompaniesProfile

Macromoltek

Computational antibody design 


Company Size

11 - 50 employees

Year Founded

2010


About Macromoltek

Macromoltek: Revolutionizing antibody design.

Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods and have are already designing antibodies for large biopharmas and smaller biotechs.

Founders & Key People

Susana Kaufmann

Susana Kaufmann

Co-founder of Macromoltek

Monica Berrondo

Monica Berrondo

Founder/CEO, Macromoltek

Share This Profile

More Companies

LotusPay

Recurring payments solution for businesses in India.

Makrwatch

Scale new user acquisition with YouTube Creators

HyperGlue

Business intelligence on text

Greywing

The Operating System for Maritime

BrainHi

Automated receptionist that answers missed calls for local businesses

voize

App for healthcare workers to fill out forms using speech

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2025 BEAMSTART. All Rights Reserved.